Abstract
Spirodioxolanes were identified as a new series of direct-acting nsP2 helicase inhibitors with activity against alphaviruses. Analogs such as 6b maintained activity against viral mutants with resistance to first-generation nsP2 helicase inhibitors.
Funding Information
  • Center for Scientific Review (1U19AI171292-01)
  • Center for Scientific Review (S10OD032476)

This publication has 14 references indexed in Scilit: